The genomics industry revolves around the study and manipulation of genomes for health and biotechnology applications. Companies here engage in activities ranging from genetic sequencing and bioinformatics to precision medicine and epigenetic research. With advancements like CRISPR technology and next-generation sequencing transforming traditional healthcare, companies are expressing growing interest in personalized therapies and diagnostics. This industry is intensifying its focus on integrating genomic data with real-world applications, showing great promise for improving disease treatment and management. As research continues to flourish, companies are now gearing up to face evolving regulatory landscapes and ethical considerations tied to genetic data.

This list showcases 28 companies specializing in genomics, each varying in size and operational scope. Headquartered predominantly in the United States and Asia, these firms were founded between the late 1990s and mid-2018s, illustrating the industry's explosive growth. While some companies like Foundation Medicine emphasize precision oncology, others such as Macrogen focus on genetic testing for wellness and disease prediction. The workforce ranges significantly, from startups with fewer than fifty employees to well-established organizations with thousands of staff, reflecting a broad spectrum of specialization in genomic sciences.

Read on to discover insights about top genomics companies.

Top 28 Genomics Companies Companies

1. Foundation Medicine

• Website: foundationmedicine.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 95%, Germany 3%, Other 1%
• Latest funding: $2.4B, January 2015
• Founded year: 2010
• Headcount: 1001-5000
• LinkedIn: foundation-medicine

Foundation Medicine, Inc., founded in 2010 and based in Boston, Massachusetts, is a biotechnology company that specializes in genomic profiling specifically for cancer treatment. The company offers a range of genomic tests, including FoundationOne CDx, FoundationOne Liquid CDx, and FoundationOne Heme, which analyze genetic alterations in tumors to guide treatment decisions. These tests are designed to provide healthcare providers with actionable insights that can lead to targeted therapies and facilitate patient enrollment in clinical trials. Foundation Medicine has established itself as a key player in the field of precision oncology, with a significant focus on developing companion diagnostics that align with approved therapies. The company has delivered over one million reports and has contributed to more than 800 peer-reviewed publications, showcasing its commitment to research and clinical application. Foundation Medicine's extensive genomic database, FoundationCore®, is one of the largest in the world, aiding in the understanding of tumor biology and the development of new therapies. The company has also received substantial funding, totaling $2.4 billion, which underscores investor confidence in its mission and capabilities.

2. Macrogen Inc.

• Website: macrogen.com
• Ownership type: Private
• Headquarters: Seoul, Seoul, South Korea
• Employee distribution: South Korea 95%, Other 5%
• Founded year: 1997
• Headcount: 201-500
• LinkedIn: macrogen-inc-

Macrogen Inc., based in Seoul, South Korea, is a private genomic analysis company that has been operational since 1997. With a workforce of approximately 201-500 employees, Macrogen specializes in a range of healthcare services that leverage genetic testing and analysis. Their offerings include disease prediction, wellness genetic tests, and precision medicine, catering to both individual consumers and research institutions. The company is particularly focused on improving health outcomes through advanced genomic analysis. Macrogen operates several institutes, such as the Precision Medicine Institute and the Bioinformatics Institute, which underscore its commitment to research and development in genomics. Additionally, they provide a comprehensive suite of research services, including next-generation sequencing (NGS) and clinical services aimed at cancer risk prediction and genetic testing. Macrogen's global presence is marked by partnerships with various international organizations, enhancing its role in the global genomics community.

3. Active Motif

• Website: activemotif.com
• Ownership type: Private
• Headquarters: Carlsbad, California, United States (USA)
• Employee distribution: United States (USA) 81%, China 5%, France 5%, Other 10%
• Latest funding: September 2021
• Founded year: 1999
• Headcount: 51-200
• LinkedIn: active-motif

Active Motif, founded in 1999 and based in Carlsbad, California, is a biotechnology company that specializes in epigenetics research. The company provides a comprehensive range of products and services aimed at advancing the understanding of gene regulation and epigenetic mechanisms. Their offerings include epigenetic analysis tools, ChIP-Seq services, and various assay kits, which are primarily targeted at researchers in both academic and commercial sectors. Active Motif's products are designed to facilitate research in areas such as chromatin biology, transcription regulation, and DNA methylation. The company has established itself as a key player in the epigenetics space, contributing to significant advancements in the field. With a workforce of around 108 employees, Active Motif continues to innovate and support the scientific community in exploring the complexities of gene expression and regulation.

4. DNAnexus

• Website: dnanexus.com
• Ownership type: Private Equity
• Headquarters: Mountain View, California, United States (USA)
• Employee distribution: Czech Republic 49%, United States (USA) 42%, Vietnam 5%, Other 4%
• Latest funding: Series E-K, $200.0M, March 2022
• Founded year: 2009
• Headcount: 201-500
• LinkedIn: dnanexus

DNAnexus is a private equity-backed company based in Mountain View, California, founded in 2009. It operates a cloud-based platform designed for the management and analysis of DNA sequence data. The company serves a wide array of biomedical organizations, including pharmaceutical companies, academic medical centers, and clinical diagnostics firms. DNAnexus provides a comprehensive suite of bioinformatics tools and professional services aimed at enhancing research capabilities and improving patient care. With over 105 petabytes of precision health data on its platform and a user base exceeding 45,000, DNAnexus is positioned as a significant player in the genomics sector. The company has also secured substantial funding, with its latest round raising $200 million in March 2022, reflecting strong market interest and confidence in its offerings.

5. Strand Life Sciences

• Website: strandls.com
• Ownership type: Corporate
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 99%, Other 1%
• Latest funding: $53.8M, September 2021
• Founded year: 2000
• Headcount: 201-500
• LinkedIn: strand-life-sciences

Strand Life Sciences, based in Bengaluru, Karnataka, India, is a corporate entity founded in 2000. The company specializes in bioinformatics and software development tailored for life sciences research. Their offerings include solutions for next-generation sequencing (NGS) and PCR diagnostics, as well as support for pharmaceutical and biomarker discovery. Strand Life Sciences has developed custom software applications that cater to the needs of pharmaceutical companies and diagnostic laboratories, enhancing research and clinical outcomes. With a workforce of approximately 622 employees, the company has completed over 500 projects in genomics, showcasing its extensive experience. Strand Life Sciences operates primarily in India but maintains a strong presence in the global genomics market, indicating its commitment to advancing precision medicine. The company has also secured funding, with a reported amount of over 53 million USD as of September 2021, which underscores its growth potential and investor interest.

6. OncoDNA

• Website: oncodna.com
• Ownership type: Private Equity
• Headquarters: Charleroi, Wallonia, Belgium
• Employee distribution: Belgium 69%, Spain 15%, France 8%, Other 8%
• Latest funding: Series B, $20.6M, February 2020
• Founded year: 2012
• Headcount: 51-200
• LinkedIn: oncodna-sa

OncoDNA, founded in 2012 and based in Charleroi, Belgium, is a biotechnology firm that focuses on precision medicine and genomic testing. The company offers innovative solutions such as the OncoDEEP® and OncoSELECT® Kits, which are designed for biomarker testing in oncology. These kits enable healthcare professionals to tailor treatment strategies based on the genetic profiles of patients, thereby improving patient outcomes. OncoDNA serves a wide range of clients, including oncology professionals, laboratories, and pharmaceutical companies, highlighting its integral role in the healthcare ecosystem. The company has also received significant funding, with a Series B round amounting to approximately €20.6 million in early 2020, indicating investor confidence and potential for growth. Their commitment to advancing precision medicine is evident in their ongoing research and development efforts, as well as their participation in clinical trials and partnerships within the industry.

7. Medgenome

• Website: medgenome.com
• Ownership type: Private
• Headquarters: Bengaluru, Karnataka, India
• Employee distribution: India 96%, United States (USA) 3%
• Founded year: 2013
• Headcount: 1001-5000
• LinkedIn: medgenomelabs

MedGenome, founded in 2013 and based in Bengaluru, India, is a private genomics service provider that specializes in sequencing and bioinformatics solutions. The company offers a wide array of services, including DNA sequencing, immune profiling, and multiomics research, catering to academic and industry researchers across the globe. MedGenome operates with a strong emphasis on advancing precision medicine, aiming to improve healthcare outcomes through high-quality genomic data and insights. With a significant operational footprint that includes facilities in the United States and partnerships with over 500 hospitals, MedGenome has sequenced more than 600,000 samples from over 400,000 patients. Their commitment to innovation is evident in their recent enhancements to omics insights and their role in the GenomeAsia 100K initiative, which seeks to increase genomic representation from Asian populations. MedGenome's expertise is further underscored by their extensive publication record, with over 200 peer-reviewed articles contributing to the scientific community.

8. Mission Bio

• Website: missionbio.com
• Ownership type: Venture Capital
• Headquarters: South San Francisco, California, United States (USA)
• Employee distribution: United States (USA) 95%, United Kingdom (UK) 2%, Netherlands 2%
• Latest funding: Other (Debt), $40.0M, January 2022
• Founded year: 2014
• Headcount: 51-200
• LinkedIn: mission-bio

Mission Bio, founded in 2014 and based in South San Francisco, California, is a biotechnology firm that focuses on single-cell technology and genomic analysis. The company provides innovative tools and services aimed at biopharmaceutical companies and research institutions, with a strong emphasis on oncology research, precision medicine, and genome editing. Their flagship product, the Tapestri Platform, enables researchers to conduct multi-omics analysis, allowing for simultaneous measurement of genetic variations and protein data from individual cells. This capability is crucial for understanding the complexities of cancer and supporting the development of targeted therapies. Mission Bio has received significant funding, with a reported amount of $40 million in 2022, which underscores their growth and relevance in the industry.

9. Element Biosciences

• Website: elementbiosciences.com
• Ownership type: Venture Capital
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 93%, Other 7%
• Latest funding: Series D, $277.0M, July 2024
• Founded year: 2017
• Headcount: 201-500
• LinkedIn: elembio

Element Biosciences, founded in 2017 and based in San Diego, California, is a biotechnology firm that focuses on advanced sequencing technologies. The company offers innovative products such as the AVITI System, a benchtop sequencer designed to provide high performance, flexibility, and cost efficiency. Their Cloudbreak sequencing kits complement the AVITI System, enabling researchers to conduct a variety of genomic analyses with high accuracy. Element Biosciences aims to enhance research capabilities in genomics and life sciences, making sequencing more accessible and affordable. The company has attracted substantial venture capital funding, with a recent Series D round raising $277 million in July 2024, which underscores its potential for growth and its commitment to advancing genetic analysis. Their technology is designed to meet the needs of scientists, allowing for improved data quality and reduced costs in genomic research.

10. Mgi

• Website: en.mgi-tech.com
• Ownership type: Private
• Headquarters: Shenzhen, Guangdong, China
• Employee distribution: China 35%, Germany 8%, Australia 6%, Other 51%
• Founded year: 2016
• Headcount: 1001-5000
• LinkedIn: mgi-bgi

MGI Tech Co., Ltd. is a biotechnology firm based in Shenzhen, Guangdong, China, founded in 2016. The company focuses on genetic sequencing and multi-omics solutions, offering a comprehensive array of products that cater to research institutions and healthcare providers. Their product lineup includes advanced genetic sequencers, sequencing reagents, library preparation kits, and lab automation tools. MGI is dedicated to driving innovation in life sciences, with applications in precision medicine and agricultural genomics. The company has a strong emphasis on research and development, with a significant portion of its workforce dedicated to this area. MGI operates globally, serving a diverse customer base across more than 100 countries, which underscores its relevance and impact in the genomics industry.

11. Arima Genomics

• Website: arimagenomics.com
• Ownership type: Venture Capital
• Headquarters: Carlsbad, California, United States (USA)
• Employee distribution: United States (USA) 91%, Spain 4%, United Kingdom (UK) 4%
• Latest funding: Series B, $7.0M, March 2022
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: arima-genomics-inc-

Arima Genomics, founded in 2015 and based in Carlsbad, California, is a biotechnology firm dedicated to advancing genomics and life sciences. The company specializes in providing cutting-edge genomic technologies and bioinformatics solutions tailored for researchers in cancer genomics and human health. Their product lineup includes Genome-Wide HiC, Arima SV Detection Assay, and various custom capture options, all designed to enhance genomic research and diagnostics. Arima Genomics has also established a strong presence in the industry through partnerships and collaborations, such as their recent agreements to make their Gene Fusion Test widely available in clinical laboratories. With a workforce of around 46 employees and a significant funding round of $7 million in March 2022, Arima is positioned to continue its growth and impact in the genomics sector.

12. Paragon Genomics

• Website: paragongenomics.com
• Ownership type: Venture Capital
• Headquarters: Fremont, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $8.0M, September 2017
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: paragon-genomics-inc.

Paragon Genomics, founded in 2015 and based in Fremont, California, is a biotechnology firm that specializes in next-generation sequencing (NGS) technologies. The company offers a variety of products, including CleanPlex NGS kits and custom panel solutions, primarily targeting research institutions and laboratories. Their product line addresses critical areas such as infectious diseases, oncology, and genetic disorders, providing high-quality and efficient genomic testing solutions. Paragon Genomics has delivered over 1,600 custom NGS panels to more than 300 labs globally, showcasing their commitment to supporting researchers in their genomic endeavors. The company raised $8 million in Series A funding in 2017, which has likely contributed to their growth and innovation in the genomics space.

13. Helix

• Website: helix.com
• Ownership type: Private Equity
• Headquarters: San Mateo, California, United States (USA)
• Employee distribution: United States (USA) 90%, Mexico 7%, Sweden 2%, Other 1%
• Latest funding: Series C, $50.0M, June 2021
• Founded year: 2015
• Headcount: 51-200
• LinkedIn: my-helix

Helix, based in San Mateo, California, is a private equity-backed healthcare service provider that specializes in genomics. Founded in 2015, the company offers a variety of genetic testing services aimed at improving patient care and supporting research in precision medicine. Their offerings include hereditary cancer and cardiovascular testing, pharmacogenomics, and proactive screening. Helix works closely with health systems and life sciences organizations to integrate genomic data into healthcare practices, thereby enhancing patient outcomes. The company has also engaged in significant initiatives, such as the Healthy Nevada Project, which aims to provide large-scale genetic screening and research. With a workforce of around 545 employees and a recent funding round of $50 million in June 2021, Helix is positioned to continue its growth and impact in the genomics field.

14. Edico Genome

• Website: edicogenome.com
• Ownership type: Corporate
• Headquarters: San Diego, California, United States (USA)
• Latest funding: $100.0M, May 2018
• Founded year: 2013
• Headcount: 51-200
• LinkedIn: edico-genome

Edico Genome is a biotechnology company founded in 2013 and located in San Diego, California. The company specializes in genomics and next-generation sequencing technologies, providing solutions that enhance genomic research and patient diagnostics. Edico Genome is particularly known for its DRAGEN platform, which offers rapid and efficient genomic data analysis, significantly reducing the time required for processing large datasets. This technology is utilized by research institutions and clinical laboratories, making it a valuable asset in the field of genomics. In 2018, Edico Genome received substantial funding of $100 million, which underscores its potential and relevance in the industry. The company's focus on innovation and efficiency in genomic data processing positions it as a noteworthy entity in the genomics sector.

15. Eurofins Genomics

• Website: eurofinsgenomics.eu
• Ownership type: Private
• Headquarters: Ebersberg, Bavaria, Germany
• Employee distribution: Germany 52%, United States (USA) 15%, Denmark 14%, Other 18%
• Founded year: 1990
• Headcount: 201-500
• LinkedIn: eurofinsgenomics

Eurofins Genomics, founded in 1990 and based in Ebersberg, Bavaria, Germany, is a private biotechnology company that specializes in genomics services. With a workforce of approximately 325 employees, the company provides a comprehensive suite of services including DNA and RNA sequencing, gene synthesis, and various molecular biology applications. Eurofins Genomics serves a wide range of clients, from academic institutions to research organizations and industrial partners, ensuring high-quality genomic solutions tailored for research and development. Their offerings support critical applications in the biotechnology and pharmaceutical sectors, reflecting their commitment to precision and reliability. The company has established itself as a key player in the genomics field, leveraging over 25 years of experience to optimize research processes and enhance scientific outcomes.

16. Phase Genomics

• Website: phasegenomics.com
• Ownership type: Venture Capital
• Headquarters: Seattle, Washington, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $1.5M, March 2024
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: phase-genomics-inc

Phase Genomics is a life sciences company based in Seattle, Washington, that specializes in genomic technologies. Established in 2015, the company has developed advanced platforms for ultra-long-range genome sequencing and metagenomics. Their solutions cater to researchers in academia and biotechnology, helping to tackle complex challenges in genomic data analysis. Phase Genomics offers products like the CytoTerra® Platform for cytogenetics and the ProxiMeta™ Platform for metagenome deconvolution. These tools enable researchers to enhance their capabilities in areas such as precision oncology, genetic disease research, and microbiome studies. The company has recently secured $1.5 million in funding, reflecting continued interest in their innovative approaches to genomic research. Their technology is designed to empower scientists to unlock new insights in health and environmental sciences, making them a notable player in the genomics field.

17. Cantata Bio

• Website: cantatabio.com
• Ownership type: Private
• Headquarters: Scotts Valley, California, United States (USA)
• Employee distribution: United States (USA) 86%, Spain 14%
• Founded year: 2022
• Headcount: 51-200
• LinkedIn: cantata-bio

Cantata Bio, based in Scotts Valley, California, is a private biotechnology company founded in 2022. The company focuses on genomic, epigenomic, and metagenomic solutions, providing advanced tools and services to researchers and clinicians. Their offerings include innovative products and software-as-a-service (SaaS) solutions designed to enhance research capabilities across various fields, including human health and agriculture. Cantata Bio operates through its subsidiaries, Dovetail Genomics and Arc Bio, which are known for their multi-omic products that unlock access to genomic information at unprecedented levels. Their services address complex scientific challenges, such as chromatin topology analysis and microbial detection, making them a significant player in the genomics industry.

18. Jumpcode Genomics

• Website: jumpcodegenomics.com
• Ownership type: Venture Capital
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $21.0M, January 2021
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: jumpcodegenomics

Jumpcode Genomics, founded in 2016 and based in San Diego, California, is a biotechnology firm focused on genomic analysis and RNA sequencing technologies. The company aims to improve the sensitivity and specificity of genomic data, addressing the challenges faced by researchers and biopharma companies in dealing with uninformative sequencing data. Their product offerings include the DepleteX Single Cell RNA Boost Kit and various CRISPRclean reagents, which are designed to enhance the quality of genomic analysis by removing unwanted sequences from samples. Jumpcode Genomics has received significant venture capital funding, with a notable Series B round raising $21 million in January 2021, reflecting strong investor confidence in their innovative solutions and market potential.

19. Cambridge Epigenetix

• Website: cambridge-epigenetix.com
• Ownership type: Private Equity
• Headquarters: Cambridge, England, United Kingdom (UK)
• Latest funding: Series D, $88.0M, November 2021
• Founded year: 2012
• Headcount: 51-200
• LinkedIn: cambridge-epigenetix

Cambridge Epigenetix, now operating under the name biomodal, is a biotechnology firm based in Cambridge, England. Founded in 2012, the company focuses on multiomic analysis and genetic sequencing technologies. Their innovative products are designed to facilitate research in critical areas such as cancer, neurodegenerative diseases, and precision medicine. By enabling researchers to analyze both genetic and epigenetic data from a single sample, biomodal provides tools that enhance understanding of complex biological processes. The company has attracted significant investment, securing $88 million in a Series D funding round in November 2021, which underscores its active role in the genomics industry and its commitment to advancing scientific research.

20. Pierian

• Website: pieriandx.com
• Ownership type: Private Equity
• Headquarters: Creve Coeur, Missouri, United States (USA)
• Employee distribution: India 87%, United States (USA) 13%
• Latest funding: January 2023
• Founded year: 2014
• Headcount: 201-500
• LinkedIn: pieriandx

Pierian, now known as Velsera, is a clinical genomics technology provider based in Creve Coeur, Missouri. Founded in 2014, the company specializes in advanced genomic analysis and reporting solutions aimed at improving patient care through precision medicine. Their flagship products include the Clinical Genomics Workspace, which streamlines the analysis and interpretation of genomic data, and the Genomics Knowledgebase, which offers a robust set of curated genomic interpretations and clinical guidelines. Pierian has built a strong network of over 140 partner sites worldwide, supporting the clinical adoption of next-generation sequencing (NGS) technologies. The company emphasizes collaboration with healthcare providers and laboratories to enhance the quality and efficiency of genomic testing. Their focus on integrating genomic insights into clinical workflows positions them as a significant player in the genomics industry.

21. SeqMatic

• Website: seqmatic.com
• Ownership type: Private
• Headquarters: Fremont, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: seqmatic

SeqMatic, founded in 2012 and based in Fremont, California, is a private company that provides a range of genomics services. They specialize in next-generation sequencing (NGS) and omics research solutions, offering services that include DNA and RNA sequencing, bioinformatics, and histopathology. Their clientele primarily consists of businesses and research institutions in the biotechnology and pharmaceutical sectors. SeqMatic operates from a CLIA-licensed and CAP-accredited laboratory, ensuring compliance with high standards of quality and reliability. The company has established itself as a certified service provider for major sequencing platforms, including Illumina and 10x Genomics. Their focus on rapid turnaround times and tailored services reflects their commitment to supporting scientific discovery and innovation in genomics.

22. Psomagen

• Website: psomagen.com
• Ownership type: Private
• Headquarters: Rockville, Maryland, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 51-200
• LinkedIn: psomagen

Psomagen, founded in 2012 and based in Rockville, Maryland, is a private biotechnology company that specializes in multiomics services and data analysis. The company provides a comprehensive suite of genomic and proteomic services tailored for researchers and clinicians in the life sciences and healthcare sectors. Psomagen operates CLIA-certified and CAP-accredited laboratories, which underscores their commitment to delivering high-quality data analysis for diagnostic and research purposes. Their service offerings include whole genome sequencing, whole exome sequencing, targeted gene sequencing, and various other genomic analyses. Psomagen also emphasizes a collaborative approach, working closely with clients to meet their specific research needs. This focus on quality and customer service has positioned Psomagen as a valuable partner in the genomics industry.

23. Genoox

• Website: genoox.com
• Ownership type: Venture Capital
• Headquarters: Palo Alto, California, United States (USA)
• Employee distribution: Israel 90%, Spain 5%, Germany 5%
• Latest funding: Series B, $8.0M, February 2021
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: genoox

Genoox, founded in 2014 and based in Palo Alto, California, is a healthcare technology company that specializes in genomic data analysis. The company offers a platform that provides critical insights for clinical genetics, biopharma, and healthcare systems. Their mission is to create the largest real-world evidence network of genomic and clinical data, making genomic data accessible and actionable at the point of care. Genoox serves healthcare providers and research institutions globally, with a strong emphasis on community engagement to enhance genomic insights. The company has received $8 million in Series B funding as of February 2021, which supports its ongoing development and expansion in the genomics space. With deployments in 44 countries and partnerships with over 1,700 organizations, Genoox is positioned to impact patient care significantly and accelerate drug development through its innovative solutions.

24. Dovetail Genomics

• Website: dovetailgenomics.com
• Ownership type: Private
• Headquarters: Scotts Valley, California, United States (USA)
• Employee distribution: United States (USA) 83%, United Kingdom (UK) 9%, Australia 9%
• Latest funding: Other (Grant), $2.0M, November 2024
• Founded year: 2013
• Headcount: 11-50
• LinkedIn: dovetail-genomics-llc

Dovetail Genomics, founded in 2013 and based in Scotts Valley, California, is a private biotechnology firm that specializes in genomic solutions. The company offers a variety of products and services aimed at researchers and clinicians, focusing on genome assembly and epigenetics. Their proprietary technologies, such as the Hi-C kits, enable high-resolution genome mapping and analysis of chromatin structure. Dovetail Genomics has established itself as a key player in the genomics industry, providing tools that facilitate complex genomic research across various scientific fields. The company has also received funding, including a grant of $2 million in November 2024, which underscores its active role in advancing genomic technologies and supporting scientific inquiry.

25. Ultima Genomics

• Website: ultimagenomics.com
• Ownership type: Private Equity
• Headquarters: Fremont, California, United States (USA)
• Employee distribution: United States (USA) 80%, Israel 18%, Other 2%
• Latest funding: $600.0M, May 2022
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: ultimagenomics

Ultima Genomics, Inc. is a biotechnology firm based in Fremont, California, specializing in high-throughput genomic sequencing technologies. Established in 2016, the company has developed the UG 100™ Sequencer, which aims to revolutionize the cost of genomic sequencing by delivering the $100 genome. This innovative approach is designed to enhance access to genomic data for researchers and healthcare providers alike. Ultima Genomics also offers ppmSeq for rare event detection, catering to critical applications in germline genetics, tumor profiling, and single-cell sequencing. The company has raised approximately $600 million in funding, showcasing strong backing from investors who share its vision for advancing human health through scalable genomic information. Ultima is actively collaborating with leading scientists and institutions, further solidifying its role in the genomics industry.

26. Golden Helix, Inc.

• Website: goldenhelix.com
• Ownership type: Private
• Headquarters: Bozeman, Montana, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), $400,000, September 2023
• Founded year: 1998
• Headcount: 11-50
• LinkedIn: golden-helix-inc.

Golden Helix, Inc., founded in 1998 and based in Bozeman, Montana, is a bioinformatics company that specializes in genomic data analysis software and clinical solutions. The company develops a suite of products designed to streamline genetic testing workflows, including tools for variant interpretation and reporting. Their software is utilized by commercial testing labs, hospital labs, and research institutions, making it integral to the clinical and research aspects of genomics. Golden Helix's offerings include VarSeq, VSClinical, and VSWarehouse, among others, which cater to various diagnostic focuses such as cancer, hereditary diseases, and pharmacogenomics. The company operates on a subscription model, allowing clients to manage costs effectively while accessing comprehensive genomic analysis tools. In September 2023, Golden Helix secured a grant of $400,000, indicating continued investment in their technology and services, which enhances their position in the genomics industry.

27. Nabsys

• Website: nabsys.com
• Ownership type: Corporate
• Headquarters: Providence, Rhode Island, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2024
• Founded year: 2004
• Headcount: 11-50
• LinkedIn: nabsys

Nabsys is a biotechnology company based in Providence, Rhode Island, founded in 2004. The firm specializes in electronic genome mapping and structural variant analysis, providing researchers and clinicians with advanced tools for genomic analysis. Their flagship products include the OhmX Analyzer, which facilitates high-resolution structural variant detection, and the Human Chromosome Explorer, a software suite that aids in genome assembly and variant identification. Nabsys aims to improve the understanding of genetic variations and their implications for health, particularly in areas like cancer research, rare diseases, and precision medicine. The company is committed to making genomic analysis more accessible and cost-effective, thereby enhancing diagnostic capabilities and patient outcomes.

28. ArrayGen Technologies Private Limited

• Website: arraygen.com
• Ownership type: Private
• Headquarters: Pune, Maharashtra, India
• Employee distribution: India 100%
• Founded year: 2014
• Headcount: 1-10
• LinkedIn: arraygen-technologies

ArrayGen Technologies Private Limited, based in Pune, Maharashtra, India, is a bioinformatics service provider that has been operational since 2014. The company specializes in genomic data analysis, offering services such as next-generation sequencing (NGS), microarray data analysis, and custom bioinformatics solutions. ArrayGen also provides training and workshops aimed at researchers and academic institutions, helping to build expertise in genomic data management and analysis. Their product offerings include gene expression arrays and a genome browser designed for efficient visualization of genomic data. With a focus on both industry and academia, ArrayGen has successfully delivered numerous genomics projects, contributing to advancements in the field. Their commitment to quality and precision in bioinformatics services has garnered positive feedback from clients, further solidifying their position in the genomics sector.

Genomics Companies Insights: Key Companies

Company	Headquarter	Size	Founded	Ownership
Foundation Medicine	Boston, Massachusetts, United States (USA)	1001-5000	2010	Corporate
Macrogen Inc.	Seoul, Seoul, South Korea	201-500	1997	Private
Active Motif	Carlsbad, California, United States (USA)	51-200	1999	Private
DNAnexus	Mountain View, California, United States (USA)	201-500	2009	Private Equity
Strand Life Sciences	Bengaluru, Karnataka, India	201-500	2000	Corporate
OncoDNA	Charleroi, Wallonia, Belgium	51-200	2012	Private Equity
Medgenome	Bengaluru, Karnataka, India	1001-5000	2013	Private
Mission Bio	South San Francisco, California, United States (USA)	51-200	2014	Venture Capital
Element Biosciences	San Diego, California, United States (USA)	201-500	2017	Venture Capital
Mgi	Shenzhen, Guangdong, China	1001-5000	2016	Private
Arima Genomics	Carlsbad, California, United States (USA)	11-50	2015	Venture Capital
Paragon Genomics	Fremont, California, United States (USA)	11-50	2015	Venture Capital
Helix	San Mateo, California, United States (USA)	51-200	2015	Private Equity
Edico Genome	San Diego, California, United States (USA)	51-200	2013	Corporate
Eurofins Genomics	Ebersberg, Bavaria, Germany	201-500	1990	Private
Phase Genomics	Seattle, Washington, United States (USA)	11-50	2015	Venture Capital
Cantata Bio	Scotts Valley, California, United States (USA)	51-200	2022	Private
Jumpcode Genomics	San Diego, California, United States (USA)	11-50	2016	Venture Capital
Cambridge Epigenetix	Cambridge, England, United Kingdom (UK)	51-200	2012	Private Equity
Pierian	Creve Coeur, Missouri, United States (USA)	201-500	2014	Private Equity
SeqMatic	Fremont, California, United States (USA)	11-50	2012	Private
Psomagen	Rockville, Maryland, United States (USA)	51-200	2012	Private
Genoox	Palo Alto, California, United States (USA)	11-50	2014	Venture Capital
Dovetail Genomics	Scotts Valley, California, United States (USA)	11-50	2013	Private
Ultima Genomics	Fremont, California, United States (USA)	201-500	2016	Private Equity
Golden Helix, Inc.	Bozeman, Montana, United States (USA)	11-50	1998	Private
Nabsys	Providence, Rhode Island, United States (USA)	11-50	2004	Corporate
ArrayGen Technologies Private Limited	Pune, Maharashtra, India	1-10	2014	Private

Want to Find More Genomics Companies Companies?

If you want to find more companies that offer genomic testing, analysis, and bioinformatics solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!